Clinical trials
Phase 1 Urinary Bladder Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
264 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 6 |
| 2001 | 5 |
| 2002 | 1 |
| 2003 | 5 |
| 2004 | 6 |
| 2005 | 4 |
| 2006 | 7 |
| 2007 | 6 |
| 2008 | 3 |
| 2009 | 5 |
| 2010 | 5 |
| 2011 | 9 |
| 2012 | 7 |
| 2013 | 7 |
| 2014 | 5 |
| 2015 | 13 |
| 2016 | 15 |
| 2017 | 13 |
| 2018 | 10 |
| 2019 | 18 |
| 2020 | 18 |
| 2021 | 14 |
| 2022 | 15 |
| 2023 | 16 |
| 2024 | 13 |
| 2025 | 13 |
| 2026 | 10 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 135 |
| Terminated | 32 |
| Recruiting | 28 |
| Active, not recruiting | 26 |
| Unknown status | 22 |
| Withdrawn | 13 |
| Not yet recruiting | 7 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 17 |
| Memorial Sloan Kettering Cancer Center | 7 |
| M.D. Anderson Cancer Center | 6 |
| Pfizer | 6 |
| Eli Lilly and Company | 5 |
| H. Lee Moffitt Cancer Center and Research Institute | 4 |
| Jonsson Comprehensive Cancer Center | 4 |
| MacroGenics | 4 |
| University of California, Davis | 4 |
| Celldex Therapeutics | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Urinary Bladder Neoplasms | 264 |
| Carcinoma, Non-Small-Cell Lung | 77 |
| Breast Neoplasms | 68 |
| Ovarian Neoplasms | 65 |
| Stomach Neoplasms | 53 |
| Lung Neoplasms | 52 |
| Pancreatic Neoplasms | 52 |
| Prostatic Neoplasms | 52 |
| Carcinoma, Renal Cell | 51 |
| Colorectal Neoplasms | 51 |
Trials
Showing 76 to 100 of 264. Each trial links to its page on Pharma Observatory.
164 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.